Patient-Reported Outcomes In Device Trials: FDA Guidance Under Review
This article was originally published in The Gray Sheet
Executive Summary
FDA is reviewing a draft guidance on use of patient-reported outcome data in device evaluations, according to Division of Cardiovascular Devices Medical Officer Neal Muni, MD
You may also be interested in...
FDA Offers Advice On Using Patient Reports For Trial Endpoints
FDA will support the use of patient-reported data in clinical trials as long as the sponsor makes the measurement tools as robust and meaningful as possible, the agency indicates in a Feb. 3 draft guidance document to industry
FDA Offers Advice On Using Patient Reports For Trial Endpoints
FDA will support the use of patient-reported data in clinical trials as long as the sponsor makes the measurement tools as robust and meaningful as possible, the agency indicates in a Feb. 3 draft guidance document to industry
Boston Scientific Enteryx GERD Device Clears FDA With Limited Indication
Patients who respond to pharmacological treatments for gastroesophageal reflux disease (GERD) have a new therapeutic alternative in Boston Scientific's Enteryx injectable treatment system